Gefurulimab (ALXN-1720) is a bispecific human-derived antibody designed to target complement component C5 and albumin. This antibody binds specifically to C5, effectively inhibiting its activation. The dual targeting mechanism allows for enhanced circulation time and improved pharmacokinetic profile, making it a valuable tool for research in immune response and complement system disorders.
Gefurulimab (ALXN-1720) is a bispecific human-derived antibody designed to target complement component C5 and albumin. This antibody binds specifically to C5, effectively inhibiting its activation. The dual targeting mechanism allows for enhanced circulation time and improved pharmacokinetic profile, making it a valuable tool for research in immune response and complement system disorders.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
